STSN (Stemsation International) Current Ratio: 0.01 (As of Sep. 2011)


What is Stemsation International Current Ratio?

Stemsation International STSN -12.20% Current Ratio is 0.01 as of Sep. 2011.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Stemsation International's current ratio for the quarter that ended in Sep. 2011 was 0.01.

Stemsation International has a current ratio of 0.01. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Stemsation International has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Stemsation International's Current Ratio or its related term are showing as below:

STSN's Current Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.995
* Ranked among companies with meaningful Current Ratio only.

Stemsation International  (OTCPK:STSN) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Stemsation International Current Ratio Related Terms


Stemsation International Current Ratio Historical Data

* Premium members only.

The historical data trend for Stemsation International's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stemsation International Current Ratio Chart

Stemsation International Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10
Current Ratio
6.65 0.04 0.00 0.00 11.57

Stemsation International Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 11.57 0.05 0.00 0.01

STSN vs MAMP, LODE: Current Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Stemsation International's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stemsation International Current Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stemsation International's Current Ratio distribution charts can be found below:

* The bar in red indicates where Stemsation International's Current Ratio falls into.



Stemsation International Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Stemsation International's Current Ratio for the fiscal year that ended in Dec. 2010 is calculated as

Current Ratio (A: Dec. 2010 )=Total Current Assets (A: Dec. 2010 )/Total Current Liabilities (A: Dec. 2010 )
=0.081/0.007
=11.57

Stemsation International's Current Ratio for the quarter that ended in Sep. 2011 is calculated as

Current Ratio (Q: Sep. 2011 )=Total Current Assets (Q: Sep. 2011 )/Total Current Liabilities (Q: Sep. 2011 )
=0.001/0.184
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 0.01 mean?
Stemsation International (STSN) has a Current Ratio of 0.01 as of Sep. 2011.
Is Stemsation International's Current Ratio too high?
Stemsation International's current Current Ratio is 0.01. The Drug Manufacturers industry median Current Ratio is 2.00. Stemsation International's value of 0.01 is 99.5% below this industry median.
How does Stemsation International's Current Ratio compare to MAMP and LODE?
Stemsation International's Current Ratio of 0.01 can be compared against companies in the Drug Manufacturers industry. The industry median Current Ratio is 2.00. Stemsation International's value of 0.01 is 99.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 998 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stemsation International's current Current Ratio of 0.01 is 99.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stemsation International's current Current Ratio is 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stemsation International stock overvalued right now?
Stemsation International (STSN) has a current Current Ratio of 0.01. The current Current Ratio is 0.01 and 99.5% below the Drug Manufacturers industry median of 2.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Stemsation International (STSN), the current Current Ratio is 0.01 as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Stemsation International Business Description

Address 9555 Bergamot Street, Lake Worth, FL, USA, 33467
Stemsation International Inc is developing a line of canned, flavored oxygen products to be sold business-to-business (B2B) and direct to consumers (DTC). These products will be distributed to the beverage industry, as well as to restaurants and bars. It is also developing R&D and manufacturing relationships for additional products and services.